Puma Biotechnology, Inc. (PBYI)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
After hours:
| Previous Close | 4.9600 |
| Open | 5.1000 |
| Bid | 4.8500 x 400 |
| Ask | 4.8900 x 200 |
| Day's Range | 4.8100 - 5.2600 |
| 52 Week Range | 2.1300 - 7.7300 |
| Volume | |
| Avg. Volume | 585,132 |
| Market Cap | 234.441M |
| Beta (5Y Monthly) | N/A |
| PE Ratio (TTM) | 10.80 |
| EPS (TTM) | 0.4500 |
| Earnings Date | Aug 01, 2024 - Aug 05, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 4.33 |
Insider MonkeyPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript
Puma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call Transcript May 2, 2024 Puma Biotechnology, Inc. beats earnings expectations. Reported EPS is $-0.05, expectations were $-0.16. PBYI isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Camilla, […]
ZacksPuma Biotechnology's (PBYI) Q1 Earnings and Revenues Beat
Puma Biotechnology (PBYI) reports narrower-than-expected first-quarter 2024 loss. The company maintains its revenue guidance for 2024.
- GuruFocus.com
Puma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...
Insights into Puma Biotechnology's Q1 2024 earnings, strategic initiatives, and future outlook amidst fluctuating revenues and expanding global presence.
© 2024 Yahoo. All rights reserved.